Boston Scientific Corporation (NYSE: BSX) today announced data supporting the use of the FARAPULSE™ Pulsed Field Ablation ...

Jim Harbaugh has a busy offseason ahead of him. Here's what to know about his heart condition, cardiac ablations and recovery ...

Dofetilide is under clinical development by Hyloris Pharmaceuticals and currently in Phase I for Atrial Flutter.

A New Pacemaker Algorithm for the Treatment of Atrial Fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT) Electrophysiologic Characteristics of the Spontaneous Onset and ...

Harbaugh will have a cardiac ablation and a hip replacement this offseason, he said Wednesday after the Chargers were ...

AstraZeneca's CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab has been approved in the US for the treatment of adult patients with previously untreated mantle cell lymphoma ...

The Los Angeles Chargers got some notable off the football field news this week from their head coach. The players are not ...

Looking back, Kokomo resident Mike Beatty knew he had something as a teenager, but he couldn’t put a name to it.

However, understanding of AF treatment remains suboptimal at 6 months ... 17 19 ORBIT II excluded patients with atrial flutter only, anticipated life expectancy less than 6 months, short lasting AF ...

Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...